. Cluster analyses of the instantaneous MTOC speed data in Fig. 3 E argue that MTOC repositioning is biphasic. (A) Shown is the dendrogram obtained from hierarchical cluster analysis of the instantaneous MTOC speed data in Fig. 3 E. The squared Euclidean distance on the y axis signifies the relatedness of each group of numbered observations. The largest change in squared Euclidean distance between successive levels of clustering provides the optimal number of clusters in the data sample. The two long black vertical lines in the dendrogram indicate that the kinetic data from Fig. 3 E fits best as two clusters. The green and red brackets under these two major branches contain the data points for the polarization and docking phases, respectively. (B) Shown is the Calinski and Harabatz Index chart, which is considered to be the most effective method for predicting the optimal number of clusters in a given dataset. The index value is shown on the y axis, and the rolling simulation number is shown on the x axis. The analysis was performed using the "fpc" package in R software, a Calinski and Harabatz Index of 2-6 cluster fits, and 20 rolling simulations. The figure shows that the two-cluster fit (indicated by the number "2" across the chart) scored the highest index value in all 20 simulations. Additional cluster analyses using the Silhouette Distance Index and the Davies and Bouldin Index also indicate that the kinetic data in Fig.  3 E separates optimally into two clusters (not depicted). Together, these statistical analyses argue that MTOC repositioning occurs in two distinct kinetic steps, i.e., that it is biphasic. Figure S2 . Ciliobrevin-D treatment does not alter microtubule organization but does inhibit basic dynein functions and the accumulation of dynein at the centrosome. (A) The overall organization of the microtubule cytoskeleton (imaged using GFP-EMTB), including the normal focusing of microtubule minus ends at the centrosome (imaged using RFP-Pericentrin), is preserved after 30 min treatment with 50 µM Ciliobrevin-D (compare the control DMSO-treated cell on the left to the Ciliobrevin-D-treated cell on the right). (B) 50 µM Ciliobrevin-D, but not DMSO (or the inactive Ciliobrevin analogue; not depicted), causes the dispersal of both the Golgi apparatus (left; imaged using mCherry-TGN38) and lysosomes (right; imaged using LysoTracker red) in Jurkat T cells. Both of these effects are associated with dynein inhibition in other cell types. Dispersal of the Golgi apparatus was observed in 65% of Ciliobrevin-Dtreated cells (n = 66) compared with 14% of DMSO-treated cells (n = 28), whereas dispersal of lysosomes was observed in 83% of Ciliobrevin-D-treated cells (n = 42) compared with 9% of DMSO-treated cells (n = 45). (C) 50 µM Ciliobrevin-D, but not DMSO (or the inactive Ciliobrevin analogue; not depicted), causes a significant decrease in the normal accumulation of dynein (imaged using GFP-tagged dynein intermediate chain 2C ) at the centrosome (imaged using RFP-Pericentrin). This was seen in 95% of treated cells (n = 20). Given that the steady-state accumulation of dynein at the centrosome is presumably due to its minus end-directed movement, this result is consistent with Ciliobrevin-D inhibiting dynein motility, as reported previously (Firestone et. al., 2012) . (D) Localization of dynein imaged using DIC-2C-GFP in a T cell conjugated to a SEE+ Raji cell. Shown is a stack overlay of DIC-2C-GFP fluorescence throughout the entire volume of the T cell. Note that DIC-2C-GFP exhibits normal accumulation at the centrosome, but does not exhibit significant accumulation at the IS, in contrast to another study (Combs et. al., 2006) . (E) Western blot of whole-cell extracts prepared from control and dynein heavy chain siRNA-treated Jurkats show 90% reduction in dynein heavy chain protein level. The blot was probed with a dynein heavy chain antibody. The data for the four bars on the left were obtained using 3×GFP-EMTB to follow microtubule polymerization, whereas the data for the three bars on the right were obtained using EB3-mCherry to follow microtubule polymerization. (B) Graph showing the rates of microtubule plus-end depolymerization in untreated (UT-A and UT-B) cells and cells treated for 30 min with DMSO, 30 min with 50 µM Ciliobrevin-D, or 15 min with 100 nM nocodazole (LD NZ). The data for all of the bars except UT-B were obtained using GFP-EMTB to follow depolymerization, whereas the data for UT-B was obtained using mCherry-tubulin to follow depolymerization. The fact that the rate obtained using mCherry-tubulin (UT-B) is the same as the rate obtained using 3×GFP-EMTB (UT-A) argues that the expression of 3×GFP-EMTB does not stabilize microtubules. The numbers within each bar correspond to the number of microtubules measured. Table S1 ). (C) A stack overlay image across the entire cell volume of a representative Jurkat cell that was expressing RFP-Pericentrin to image the centrosome and 3×GFP-EMTB to image microtubules, and that had been treated for 15 min with 0.5 µM taxol, shows that this concentration of taxol does not disrupt microtubule organization, including the normal focusing of microtubule minus ends at the centrosome (this was seen in 100% of treated cells; n = 50). (D) A representative image of 3×GFP-EMTB fluorescence in a cell treated for 15 min with 100 nM NZ showing that while the dynamicity of microtubule ends has been lost (Table S1 B), the microtubule lattice is preserved.
